Grant RDF

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31
• 32
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• more...

• Algorithms for Protein Superfamily Classification and Function Prediction
• All Kids Proposal for Special Projects
• All Kids Proposal for Special Projects
• All Kids Proposal for Special Projects
• ALL Kids Proposal for Special Projects
• All Kids Proposal for Special Projects
• All Kids Proposal for Special Projects
• All Kids Proposal for Special Projects
• Allergic Contact Dermatitis: Mechanisms of Elicitation
• Alliance for Calmodulin Kinase II Signaling in Heart Disease - University of Alabama at Birmingham
• Alliance for Clinical Trials in Oncology Payment Agreement
• Alliance for Clinical Trials in Oncology Payment Agreement
• Alliance NCORP Research Base - Alliance A171603 Pilot Study
• Alpha 1 Foundation Business Associate Agreement
• Alpha M Beta 2 Integrin Blockade for Acute Inflammatory Neuropathies
• Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomaker Study of Disease
• Alpha-1 Catenin Regulation of the Mammalian Blood-Nerve Barrier
• Alpha-Galactosidase A and Glycosphingolipid Metabolites as Putative Biomarkers for PD
• Alpha-Galactosidase A as a Therapeutic Target for Parkinson's Disease
• Alpha-Galactosidase A: A Novel Target for Reducing Alpha-Synuclein Toxicity
• Alpha-Synuclein Aggregate Induced Synapse Loss is a Pathological Event contributing to Lewy Body Dementias
• Alpha-Synuclein Degradation Mechanisms
• Alpha2 Adrenergic Signaling in AD Pathogenesis
• Alphavirus nsP3 Protein: Roles of Intrinsically Disordered Region in Virus Replication and Pathogenesis
• ALPS FSP Clinical Center Participation Terms and Conditions (CCPTC) - University of Alabama
• ALSDE Literacy Act Evaluation
• ALSTATE (Alabama Lifespan Sickle Cell Tracking Access Towards Equality) Network
• ALTE11C2 Study - Health Effects after Antracycline and Radiation Therapy (HEART) - Dexazoxane and Prevention of Antracycline-Related Cardiomyopathy
• ALTE11C2 Study – Health Effects After Antracycline and Radiation Therapy (HEART) – Dexazoxane and Prevention of Antracycline-Related Cardiomyopathy
• ALTE11C2 Study - Health Effects after Antracycline and Radiation Therapy (HEART) - Dexazoxane and Prevention of Antracycline-Related Cardiomyopathy

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31
• 32
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• more...